The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAA..L Regulatory News (AA.)

  • There is currently no data for AA.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Offer Discussions

24 Sep 2020 07:45

RNS Number : 9930Z
AA PLC
24 September 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

THIS DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION 

 

FOR IMMEDIATE RELEASE

 

24 September 2020

 

 

AA plc ("AA" or the "Company")

 

Update on Offer Discussions

 

The Board of Directors of AA (the "Board") announces the following updates on the status of its discussions in relation to a possible offer for the Company and a potential refinancing of the AA group's indebtedness.

 

AA confirms that it has consented to a request from TowerBrook Capital Partners (U.K.) LLP and Warburg Pincus International LLC (together the "Consortium") to explore the possibility of a consortium offer for the entire issued and to be issued share capital of the Company. The Consortium has confirmed its strong interest in pursuing a possible all-cash offer for the Company, including an intention to de-lever the AA's capital structure significantly, consistent with the Company's objectives. Any possible offer remains subject to a number of matters including, inter alia, the completion of the Consortium's due diligence and the finalisation of documentation. The Board now intends to progress its discussions with the Consortium regarding a possible offer and a further announcement will be made in due course as appropriate. However, there can be no certainty that any offer will be made for the Company, nor as to the terms on which any offer might be made.

 

The Company also notes the announcements issued yesterday by Centerbridge Partners Europe, LLP and Platinum Equity Advisors LLC and confirms that, by mutual agreement, discussions with these parties in relation to a possible offer for the Company have now been terminated on the basis described in those announcements.

 

Notwithstanding any possible offer for the Company, the Board continues to engage with a number of other parties to assess a range of alternative potential refinancing options, including the possibility of raising new equity.

 

In accordance with Rule 2.6(a) of the Code, the Consortium must, by no later than 5.00 p.m. (London time) on 29 September 2020, either announce a firm intention to make an offer in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. Should the current discussions continue positively, however, the Board currently expects that a further extension of the deadline will be required. Such an extension would only be granted with the consent of the Panel and following a request from the Board, in accordance with Rule 2.6(c) of the Code.

 

The Company confirms its intention to publish its interim results in respect of the six months ended 31 July 2020 on 29 September 2020.

 

This announcement is being made without the approval of the Consortium.

 

The person responsible for arranging the release of this announcement on behalf of AA is Nadia Hoosen, Chief Legal Officer and Company Secretary.

 

 

Enquiries:

 

 

Media (FTI Consulting)

+44 20 3727 1340

Alex Le May

FTI_AA@fticonsulting.com

John Waples

Nick Hasell

 

Evercore

 

+44 20 7653 6000

Andrew Sibbald

Mark Hennessy

Graham Copeland

 

J.P. Morgan Cazenove

 

+44 20 7742 4000

Robert Constant

James Robinson

Alex Bruce

 

Citi

 

+44 20 7986 4000

Peter Brown

Alex de Souza

 

AA

Nadia Hoosen,

+44 7892 776 362

Chief Legal Officer &

Company Secretary

Zeeshan Maqbool,

+44 20 7395 7301

Investor Relations

 

Disclaimer

Evercore Partners International LLP ("Evercore"), which is authorised and regulated by the Financial Conduct Authority in the UK, is acting exclusively as financial adviser to AA and no one else in connection with the matters described in this announcement and will not be responsible to anyone other than AA for providing the protections afforded to clients of Evercore nor for providing advice in connection with the matters referred to herein. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Evercore in connection with this announcement, any statement contained herein, any offer or otherwise. Apart from any responsibilities and liabilities (including, without limitation, those imposed on Evercore by the Financial Services and Markets Act 2000 or under the regulatory regime of any other jurisdiction) which would make the exclusion of liability unlawful, to the fullest extent permitted by applicable law, Evercore and its affiliates disclaim all and any responsibility or liability in respect of this announcement or any statement contained herein.

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for AA and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than AA for providing the protections afforded to clients of J.P. Morgan Cazenove, or for providing advice in relation to any matter referred to herein.

Citigroup Global Markets Limited ("Citi"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated in the UK by the Financial Conduct Authority ("FCA") and the PRA, is acting as financial adviser for AA and for no one else in connection with the matters described in this announcement and will not be responsible to anyone other than AA for providing the protections afforded to clients of Citi nor for providing advice in connection with any matters referred to in this announcement. Neither Citi nor any of its affiliates, directors or employees owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, consequential, whether in contract, in tort, in delict, under statute or otherwise) to any person who is not a client of Citi in connection with this announcement, any statement contained herein, any offer or otherwise.

Publication on website

A copy of this announcement will be made available (subject to certain restrictions relating to persons resident in restricted jurisdictions) at www.theaaplc.com/investors in accordance with Rule 26.1 of the Code by no later than 12 noon (London time) on 2 September 2020. For the avoidance of doubt, the content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPSEASMLESSEDU
Date   Source Headline
10th Mar 20218:00 amRNSRemoval - AA plc
9th Mar 20213:15 pmBUSForm 8.3 - AA plc
9th Mar 20212:29 pmRNSForm 8.3 - [AA PLC / WARBURG PINCUS VENTURES]
9th Mar 202111:32 amRNSForm 8.5 (EPT/RI) - AA plc
9th Mar 202110:54 amBUSForm 8.5 (EPT/NON-RI) - AA PLC
9th Mar 202110:30 amRNSForm 8.5 (EPT/RI)- AA plc
9th Mar 20219:00 amRNSScheme of arrangement becomes effective
9th Mar 20218:47 amRNSForm 8.5 (EPT/RI) AA Plc
9th Mar 20218:39 amRNSForm 8.5 (EPT/RI)
8th Mar 20213:15 pmBUSForm 8.3 - AA plc
8th Mar 202112:28 pmRNSCourt approval of Scheme
8th Mar 202111:24 amRNSForm 8.5 (EPT/RI)- AA plc
8th Mar 202110:43 amBUSForm 8.5 (EPT/NON-RI) - AA PLC
8th Mar 202110:04 amRNSForm 8.3 - AA plc
8th Mar 20218:31 amRNSForm 8.5 (EPT/RI)
8th Mar 20218:26 amRNSForm 8.5 (EPT/RI) AA Plc
8th Mar 20218:16 amRNSForm 8.5 (EPT/RI)
5th Mar 20213:15 pmBUSForm 8.3 - AA plc
5th Mar 202111:44 amRNSForm 8.5 (EPT/RI)-AA PLC
5th Mar 202111:37 amRNSForm 8.5 (EPT/RI) - AA plc
5th Mar 202110:38 amBUSForm 8.5 (EPT/NON-RI) - AA PLC
5th Mar 20219:39 amRNSForm 8.5 (EPT/RI)
5th Mar 20219:02 amRNSForm 8.5 (EPT/RI) AA Plc
5th Mar 20218:42 amRNSForm 8.3 - AA plc
4th Mar 20213:30 pmRNSForm 8.3 - AA PLC
4th Mar 20213:15 pmBUSForm 8.3 - AA plc
4th Mar 202111:34 amRNSForm 8.5 (EPT/RI) - AA plc
4th Mar 202111:21 amRNSForm 8.5 (EPT/RI)- AA plc
4th Mar 202110:48 amBUSForm 8.5 (EPT/NON-RI) - AA PLC
4th Mar 202110:40 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - AA PLC - Ordinary Shares
4th Mar 202110:02 amRNSForm 8.3 - AA plc
4th Mar 20219:25 amRNSForm 8.5 (EPT/RI)
4th Mar 20219:09 amRNSForm 8.5 (EPT/RI)
4th Mar 20219:02 amRNSForm 8.5 (EPT/RI) AA Plc
3rd Mar 20213:30 pmRNSForm 8.3 - AA PLC
3rd Mar 20213:15 pmBUSForm 8.3 - AA plc
3rd Mar 20212:12 pmRNSForm 8.3 - AA PLC
3rd Mar 202111:33 amRNSForm 8.5 (EPT/RI) - AA plc
3rd Mar 202111:33 amRNSForm 8.5 (EPT/RI)- AA plc
3rd Mar 202111:27 amBUSForm 8.5 (EPT/NON-RI) - AA PLC
3rd Mar 202110:23 amRNSForm 8.3 - AA plc
3rd Mar 202110:06 amRNSForm 8.5 (EPT/RI)
3rd Mar 20217:31 amRNSForm 8.5 (EPT/RI) AA Plc
2nd Mar 20215:30 pmRNSAA
2nd Mar 20212:07 pmRNSForm 8.3 - AA PLC
2nd Mar 202111:38 amRNSForm 8.5 (EPT/RI) - AA plc
2nd Mar 202111:25 amRNSForm 8.5 (EPT/RI)- AA plc
2nd Mar 202110:57 amRNSForm 8.5 (EPT/RI)
2nd Mar 202110:48 amBUSForm 8.5 (EPT/NON-RI) - AA PLC
2nd Mar 202110:25 amRNSForm 8.3 - AA plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.